Takeda: strategic alliance with Canada’s enGene on gene therapy for diseases of the digestive system

enGene has developed „Gene Plii“, an oral, non-viral gene therapy based on chitosan encapsulation which allows a highly flexible nucleotide (DNA and RNAi) delivery to mucosal tissues targeting chronic diseases via the induction or suppression of protein expression levels.

Takeda news release, January 12, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny